Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
Consolidated Statements of Cash Flows (USD $)	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net loss	$ (2,540,485)us-gaap_NetIncomeLoss	$ (602,350)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense	193,120us-gaap_ShareBasedCompensation	6,141us-gaap_ShareBasedCompensation
Depreciation	10,405us-gaap_Depreciation
(Gain) loss on foreign exchange	(4,570)	2,692
Gain on settlement of notes payable, accrued interest and accounts payable	(145,006)
Forgiveness of interest on notes payable	(7,466)
Changes in fair value of derivative warrant liability	28,448us-gaap_FairValueAdjustmentOfWarrants	(1,978)us-gaap_FairValueAdjustmentOfWarrants
Non-cash interest expense	29,861us-gaap_PaidInKindInterest	41,543us-gaap_PaidInKindInterest
Changes in operating assets and liabilities:
Increase in restricted cash	(13,728)
Decrease in prepaid expenses	(268,056)
Increase in accounts payable	170,239	131,849
Increase (decrease) in accrued expenses	186,002	33,478
Net cash used in operating activities	(2,361,236)	(366,715)
Cash flows from investing activities:
Purchases of property and equipment	(64,448)
Net cash (used in) provided by investing activities	(64,448)
Cash flows from financing activities:
Proceeds from convertible bridge notes	0us-gaap_ProceedsFromConvertibleDebt	0us-gaap_ProceedsFromConvertibleDebt
Proceeds from issuance of notes payable	192,000us-gaap_ProceedsFromNotesPayable	7,252us-gaap_ProceedsFromNotesPayable
Principal payments on notes payable	(247,006)us-gaap_RepaymentsOfNotesPayable
Proceeds from issuance on common stock	10,305,161
Issuance costs incurred common stock financings	(1,865,046)
Net cash provided by financing activities	8,385,109	127,252
Net increase (decrease) in cash and cash equivalents	5,959,425	(239,463)
Cash and cash equivalent at beginning of the period	303,020	542,483
Cash and cash equivalent at end of the period	6,262,445	303,020
Supplemental disclosure of cash flow information and non cash transactions:
Conversion of notes payable, accrued interest and accounts payable into common stock and a warrant	396,000
Reclassification of derivative warrant liability to equity	48,380
Series A Convertible Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Series A convertible preferred stock		120,000
Supplemental disclosure of cash flow information and non cash transactions:
Conversion of Series A preferred stock into common stock	$ 1,108,609